Cargando…
Correction: Marked variability in bioactivity between commercially available bovine colostrum for human use; implications for clinical trials
Autores principales: | Playford, Raymond J., Cattell, Meg, Marchbank, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537875/ https://www.ncbi.nlm.nih.gov/pubmed/33022011 http://dx.doi.org/10.1371/journal.pone.0240392 |
Ejemplares similares
-
Marked variability in bioactivity between commercially available bovine colostrum for human use; implications for clinical trials
por: Playford, Raymond J., et al.
Publicado: (2020) -
Methods to improve efficacy of orally administered bioactive peptides using bovine colostrum as an exemplar
por: Playford, Raymond John, et al.
Publicado: (2021) -
Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea
por: Playford, Raymond J., et al.
Publicado: (2021) -
Protease Inhibitors Protect Bovine Colostrum or Chicken Egg Growth Factors from Pancreatic Enzyme Digestion in AGS Cells or Colitic Rats
por: Marchbank, Tania, et al.
Publicado: (2021) -
Oral bovine colostrum supplementation does not increase circulating insulin-like growth factor-1 concentration in healthy adults: results from short- and long-term administration studies
por: Davison, Glen, et al.
Publicado: (2019)